The Claim
Hepatic ceramide levels, specifically the C16:0, C18:0, and C20:0 species, are elevated in mice fed a high-fat diet supplemented with fructose or glucose and in humans with severe hepatic steatosis or metabolic dysfunction-associated steatohepatitis.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In both mice on a high-fat diet with added fructose or glucose and in humans with severe fatty liver disease, specific types of ceramide lipids in the liver are present at higher levels.
See the scientific wording
Hepatic ceramide levels, particularly C16:0, C18:0, and C20:0 species, are elevated in both mice fed a high-fat diet supplemented with fructose or glucose and in humans with severe hepatic steatosis or metabolic dysfunction-associated steatohepatitis, suggesting a conserved role for these lipids in liver injury progression across species.
Excess fat in the liver combines with sugar to make harmful fat molecules called ceramides. These ceramides damage the energy factories inside liver cells, causing toxic waste to build up. The cell's defense system tries to clean up the waste but gets overwhelmed, leading to cell damage and death. This triggers inflammation that scars the liver over time.
What the research says
1 studyStudy: No Difference in Liver Damage Induced by Isocaloric Fructose or Glucose in Mice with a High-Fat Diet
In both mice and people with severe fatty liver, certain fat molecules called ceramides are higher — and this study shows it doesn’t matter if they ate fructose or glucose; the ceramides still go up the same way.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.